http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104027336-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56d4164e2c4f9b9b4d73cd8033675c0a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2014-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8c25e8a72b0f282b75074e029b14ae4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bd93ff13ba2b06ad4ffcfbf616deecf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ca6e699210f19ea71470b1eeb93178f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_477375a2f61f3d38325db5b7a6d59fbf
publicationDate 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104027336-A
titleOfInvention Medicament composition of imatinib mesylate and preparation of medicament composition
abstract The invention relates to the field of medicaments, and in particular relates to a medicament composition of imatinib mesylate. The imatinib mesylate medicament composition comprises an imatinib mesylate hydrate, imatinib mesylate amorphous powder and medicament accessory materials. An X-ray powder diffraction diagram of the imatinib mesylate hydrate obtained by measurement of Cu-K alpha rays is shown in Figure 1. An imatinib mesylate compound disclosed by the invention has good stability, flowability, rapid dissolution and good clinical effects, and is very suitable for clinical applications.
priorityDate 2014-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454269980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID178148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412630177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22242641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6337614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448981304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451495905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407378349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493889
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283

Total number of triples: 35.